GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Restart Life Sciences Corp (OTCPK:NMLSF) » Definitions » Other Current Payables

NMLSF (Restart Life Sciences) Other Current Payables : $0.00 Mil (As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Restart Life Sciences Other Current Payables?

Restart Life Sciences's Other Current Payables for the quarter that ended in Sep. 2024 was $0.00 Mil.

Restart Life Sciences's annual Other Current Payables declined from Dec. 2020 ($0.05 Mil) to Dec. 2021 ($0.02 Mil) but then increased from Dec. 2021 ($0.02 Mil) to Dec. 2022 ($0.10 Mil).


Restart Life Sciences Other Current Payables Historical Data

The historical data trend for Restart Life Sciences's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Restart Life Sciences Other Current Payables Chart

Restart Life Sciences Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.03 0.05 0.02 0.10

Restart Life Sciences Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24 Jun24 Sep24
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.26 - - -

Restart Life Sciences Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


Restart Life Sciences Other Current Payables Related Terms

Thank you for viewing the detailed overview of Restart Life Sciences's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


Restart Life Sciences Business Description

Traded in Other Exchanges
Address
700-838 West Hastings St, Vancouver, BC, CAN, V6C 0A6
Restart Life Sciences Corp is a Canadian life sciences company dedicated to addressing today's health challenges with wellness solutions. It is focus is on creating health foods that address the needs of this community. Its Flagship developments includes Autism Spectrum, Health-Related Foods, Psilocybin Clinical Trial for Fragile X Syndrome, Orphan Drug Designation (FDA and EMA).

Restart Life Sciences Headlines

From GuruFocus

U.S. FDA Approves Nova Mentis Orphan Drug Application

By PRNewswire PRNewswire 11-02-2021

Nova Mentis Files Genetic Neuroinflammatory Disease Patent

By PRNewswire PRNewswire 11-09-2021